All companies
Visit website
THRIVELAB
OperatingThrivelab Co.
Healthcare · Fitness · Founded 2020
Healthtech platform in the hormone health space with 558% growth and $325k MRR
Post-money valuation ⓘ
$20.0M
As of Apr 2025 · from THRIVELAB Preferred Stock 2 · pre-money + amount raised, not a traded price
Total raised
$108,590
Across 2 rounds since 2023
Latest share price
$5,477.00
THRIVELAB Preferred Stock 2 offering price
Financials
FY2020–FY2025 · from SEC filings · hover any figure for its source$0
−$25K
2020
$194K
−$951K
2021
$1.8M
−$3.5M
2022
$5.4M
−$2.5M
2023
$6.1M
−$410K
2024
$5.4M
−$626K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$0
$193,662
$1,832,582
$5,370,196
$6,118,982
$5,383,830
Cost of goods sold
$1,410
$94,591
$932,036
$2,133,754
$2,406,674
$2,400,463
Gross margin
—
51%
49%
60%
61%
55%
Net income
-$24,945
-$951,123
-$3,504,170
-$2,533,143
-$410,455
-$625,837
Taxes paid
$1,234
$1,343
$10,906
$0
$0
$0
Balance sheet
Cash
$74,833
$127,796
$184,622
$56,881
$14,943
$21,516
Accounts receivable
$0
$0
$10,376
$4,167
$3,078
$4,296
Total assets
$90,674
$176,300
$256,192
$184,886
$697,283
$1,225,404
Short-term debt
$0
$80,988
$613,334
$4,928,287
$594,372
$492,288
Long-term debt
$50,000
$900,000
$3,900,000
$0
$5,094,779
$6,350,821
Total liabilities
$50,000
$980,988
$4,513,334
$4,928,287
$5,689,151
$6,843,109
Other
Headcount
—
50
—
14
—
20
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$17.3M
Valuation cap
$20.0M
post-money
Reg CF Offering (2023)
THRIVELAB Preferred Stock 2
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised — / $615.9KPost-money $20M
Raised $108.6K / $1MInvestors 69Valuation cap $17.3M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 2 of 4 annual reports (FY2022–FY2025)
69 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001964110Share price $5,477.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.